Elevated serum CA72-4 as a novel diagnostic biomarker for acute gout flares
Abstract While Glycoantigen 724 (CA72-4) is well-established as a tumor marker, its association with gout has yet to be fully explored. Our study aimed to investigate the expression levels of CA72-4 and other tumor markers at different stages of gout in patients and to assess any changes in their ex...
Saved in:
| Main Authors: | Yong Zhuang, Xin Hu, Qingyan Cai, Huibin Huang, Xinna Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-07665-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of long-term administration of various doses of colchicine in patients with gout
by: M. S. Eliseev, et al.
Published: (2025-05-01) -
Study on the Frequency and Factors Affecting Treatment Discontinuation in Gout Patients in Sari, 2023–2024
by: Yasaman Salehi, et al.
Published: (2025-03-01) -
Should all people starting urate-lowering therapy for gout receive anti-inflammatory prophylaxis?
by: Edward Roddy, et al.
Published: (2024-11-01) -
Ultrafast and Ultrasensitive Simultaneous Molecular Recognition and Quantification of CA12-5, CA72-4, HER1, and AFP in Biological Samples
by: Ruxandra-Maria Ilie-Mihai, et al.
Published: (2025-06-01) -
Prophylaxis of Gout Flares in Patients with Renal Impairment: Dosing Adjustments with Colchicine Oral Solution Informed by a Pharmacokinetic Model
by: Jaymin Shah, et al.
Published: (2025-06-01)